Medicine and Dentistry
Patient
100%
Chemoradiotherapy
58%
Biopsy
52%
Therapeutic Procedure
47%
Surveillance
45%
Surgery
45%
Vedolizumab
39%
Organoid
39%
Ustekinumab
39%
Gastrointestinal Stromal Tumor
39%
Cells
39%
Esophageal Cancer
39%
Kidney
35%
Metastatic Carcinoma
33%
Inpatient
29%
Serum
29%
Signet Ring Cell
28%
Tissues
28%
Androgen Receptor
28%
Estrogen Receptor Alpha
28%
Neoplasm
26%
Serositis
26%
Primary Tumor
25%
Enalapril Maleate
25%
Immunohistochemistry
24%
Woman
22%
Diseases
19%
Stroma
16%
Sex Difference
16%
Prevalence
16%
Interleukin 23
16%
Malignant Neoplasm
16%
SDHB
15%
Evaluation Study
14%
Association
14%
Treatment Response
12%
Prognosis
12%
Fibrosis
11%
Intestine
11%
Tumor Cell
11%
Receptor Expression
11%
Messenger RNA
11%
Prospective Cohort Study
11%
Distant Metastasis
11%
Development
11%
Dentigerous Cyst
10%
Pediatrics
10%
Adult
10%
Specimen
10%
Spontaneous Remission
9%
Nursing and Health Professions
Ustekinumab
39%
Vedolizumab
39%
Inflammation
26%
Patient
16%
Interleukin 23
16%
Blood Level
15%
Treatment Response
12%
Inflammatory Bowel Disease
9%
Remission
9%
Therapeutic Drug Monitoring
9%
Adult
7%
Patient with Inflammatory Bowel Disease
7%
Procedures
6%
Biopsy
6%
Inpatient
5%
Crohn Disease
5%
Biochemistry, Genetics and Molecular Biology
SDHA
36%
SDHB
15%
Wild Type
15%
Mutation
13%
Electric Potential
10%
Teratoma
10%
Pediatrics
10%
Germline Mutation
7%
Succinate Dehydrogenase
7%
Induced Pluripotent Stem Cell
7%
Gene Expression Profiling
7%
Sequencing
6%
Nested Gene
6%
SDHD
5%